This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
PDE4D / 3',5'-cyclic-AMP phosphodiesterase 4D · IHC design guide
Design Immunohistochemistry for PDE4D
Plan paraffin section IHC for PDE4D using the observed cytoplasmic tissue pattern and high staining in colonic glandular cells (HPA tissue IHC). The guide covers fixation consistency, antibody selection and interpretation of tissue staining.
Evidence assembled Oct 2026 · For research use; verify linked source records and product datasheet before use
PDE4D Immunohistochemistry Experimental Design Guide
Expected localisation, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.
Must know before staining
| Expected localisation | Ubiquitous cytoplasmic tissue staining (HPA tissue IHC) | |
| Staining pattern | Cytoplasmic staining; high in colonic glandular cells (HPA tissue IHC) | |
| Antigen retrieval | Citrate pH 6 HIER, heat-mediated (datasheet A01111-1) | |
| Positive control | Appendix+4 more · see all | |
| Negative control | None in HPA (detected in all 45 tissues); use no-primary + isotype controls |
Important caveats
Reasons your staining may differ from the expected pattern.
| Fixation | Keep fixation consistent across sections. (standard IHC practice; not target-specific) | |
| Caveat | Staining has uncertain concordance with RNA expression (HPA tissue IHC) | |
| Regulation | Specific expression regulators unreported (UniProt) | |
| Isoform / epitope | 12 isoforms vary at the N terminus; epitope coverage may differ (UniProt) |
Section 1
Recommended PDE4D IHC & IF Protocols
Compare the catalog antibody’s IHC-P protocol (datasheet A01111-1) with published PDE4D staining in liver (PMC12375944), rat cortex (PMC7655962), and pancreatic ductal adenocarcinoma (PMC6856734).
| Sample | Paraffin-embedded mouse lung tissue; fixative not specified (datasheet A01111-1) |
| Fixation | Image fixative and duration unreported (datasheet A01111-1); verify before use. |
| Sectioning | 4–5 µm sections on charged slides (standard) |
| Deparaffinisation | Xylene, graded ethanol series to water (standard) |
| Antigen retrieval | Heat retrieval: Citrate pH 6, 20 min (datasheet A01111-1) |
| Peroxidase block | 3% H2O2, 10 min, room temperature (standard) |
| Blocking | 10% goat serum (datasheet A01111-1) |
| Primary antibody | Rabbit anti-PDE4D, 0.5-1μg/ml (datasheet A01111-1) |
| Primary incubation | Overnight at 4 °C (datasheet A01111-1) |
| Detection | Streptavidin-biotin complex (SABC), DAB chromogen (datasheet A01111-1) |
| Counterstain | Hematoxylin, blue, dehydrate and mount (standard) |
| Expected result | PDE4D-positive staining in glandular cells of appendix (HPA tissue IHC: High). HPA tissue profile: Ubiquitous cytoplasmic expression. No signal in the no-primary control. |
💡Decision noteStart with citrate pH 6 heat retrieval for paraffin sections (datasheet A01111-1); the pancreatic study used 100°C high-pressure citrate pH 6 (PMC6856734).
Section 2
What Is the Expected PDE4D Staining Pattern?
PDE4D is found in cytoplasm and at membranes, including the apical membrane of colonic crypt cells; it has no transmembrane segment (UniProt Q08499). Expect staining in colon glandular cells and other HPA high cell populations, against a broadly cytoplasmic tissue pattern (HPA tissue IHC). Interpret intensity cautiously: tissue IHC reliability is Uncertain, with medium consistency between antibody staining and RNA expression (HPA tissue IHC).
| Cytoplasmic stain in colon glandular cells, sometimes concentrated toward the apical edge. | This fits high colon glandular-cell staining (HPA tissue IHC) and apical membrane association in colonic crypt cells (UniProt Q08499). Score cytoplasmic and apical signals separately; the expected distribution does not establish that every gland has equal intensity. |
| Signal confined to nuclei, with no convincing cytoplasmic or membrane staining. | Treat a nuclear-only IHC pattern as discordant with the ubiquitous cytoplasmic tissue profile (HPA tissue IHC) and the established cytoplasmic and membrane locations (UniProt Q08499). Review morphology and controls before calling it PDE4D. Nuclear ICC-IF locations are listed with Uncertain support (HPA subcellular). |
| Strong staining in cells outside the expected population for the selected tissue. | Check cell identification, then investigate antibody cross-reactivity or endogenous chromogen activity (general IHC practice). HPA reports high staining in specified cell populations, but its overall tissue profile is ubiquitous and its IHC reliability is Uncertain (HPA tissue IHC); unexpected cells alone cannot prove cross-reactivity. |
| Uniform color across cells, extracellular spaces, and blank areas of the section. | This distribution is more consistent with diffuse assay background than a cell-associated PDE4D pattern (general IHC practice; HPA tissue IHC). Examine the detection-only control, blocking, washes, and chromogen development before assigning the color to cytoplasm. |
| No signal in colon glandular cells or another HPA high population. | A blank result is inconclusive until section integrity and detection controls pass (general IHC practice). Colon glandular cells, cerebellar granular-layer cells, and heart cardiomyocytes are reported High (HPA tissue IHC); the HPA IHC reliability remains Uncertain, so one negative section does not settle target absence. |
💡Expected PDE4D appearanceCall an IHC section positive when identifiable colon glandular cells show clear cytoplasmic staining, with possible apical enrichment (HPA tissue IHC; UniProt Q08499); uniformly colored blank spaces or nuclear-only color are suspect patterns (general IHC practice; HPA tissue IHC).
| Compartment and topology (UniProt Q08499) | PDE4D is reported in cytoplasm, membranes, cytoskeleton, and centrosome, without a transmembrane segment (UniProt Q08499). Membrane-adjacent color can be plausible, especially at colonic crypt apices; compartment assignment still requires intact cell morphology. |
| Tissue and cell context (HPA tissue IHC) | High staining is reported in glandular cells of appendix, colon, duodenum, epididymis, and fallopian tube, among other listed populations (HPA tissue IHC). Parathyroid glandular cells, vaginal squamous cells, and soft-tissue fibroblasts are Low, not established negatives (HPA tissue IHC). |
| Isoform coverage (UniProt Q08499) | Twelve PDE4D isoforms are listed (UniProt Q08499). The supplied record gives no antibody epitope or isoform coverage, so a section's staining cannot identify an isoform, and an absent signal cannot be assigned to isoform loss. |
| Strength of staining evidence (HPA tissue IHC; HPA antibodies) | The tissue profile has Uncertain reliability and medium staining–RNA consistency (HPA tissue IHC). HPA045895 is Uncertain for IHC and Supported for ICC (HPA antibodies). Use these labels when weighing a pattern; ICC support does not upgrade IHC certainty. |
| Situation | Likely cause | Next action |
|---|---|---|
| Colon glandular cells look blank. | The expected High population may be missed, or the IHC run may have failed (HPA tissue IHC; general IHC practice). | Confirm that glands are present, then review a positive control, primary-antibody step, retrieval conditions, and detection reagents (general IHC practice). Avoid inferring a PDE4D-specific retrieval requirement from these sources. |
| Every compartment has weak, even color. | Non-specific binding, incomplete washing, or excessive chromogen development can obscure localization (general IHC practice). | Compare with a detection-only control, review blocking and wash steps, and shorten development if needed (general IHC practice). Reassess only when individual cell boundaries and cytoplasm are readable. |
| A nuclear-only pattern appears. | It conflicts with the dominant cytoplasmic tissue profile (HPA tissue IHC); nuclear ICC-IF locations have Uncertain support (HPA subcellular). | Check counterstain, focus, and detection-only control, then compare the same cell types in another well-preserved section (general IHC practice). Record the discordance instead of scoring nuclear color as confirmed PDE4D. |
| An apparently unexpected cell type stains strongly. | Cell misidentification, cross-reactivity, or endogenous detection activity are possible (general IHC practice). HPA's broad profile also limits a simple off-target judgment (HPA tissue IHC). | Verify morphology and compare a control lacking primary antibody (general IHC practice). If peroxidase detection is used, assess endogenous peroxidase blocking (general IHC practice). |
| A low-staining tissue has faint positive cells. | Low is a staining level, not a negative designation, for the listed parathyroid, vagina, and soft-tissue populations (HPA tissue IHC). | Score cell type, compartment, and intensity against matched controls (general IHC practice). Do not use those populations as proven negative controls (HPA tissue IHC). |
| Can ICC-IF localization settle an ambiguous IHC result? | HPA ICC-IF supports plasma-membrane localization, while cytosol and additional nuclear or ciliary locations are Uncertain (HPA subcellular). IHC staining reliability is separately Uncertain (HPA tissue IHC). | Use ICC-IF as context for compartment plausibility, not as validation of the paraffin-section result (HPA subcellular; HPA tissue IHC). Resolve the IHC call with section morphology and assay controls (general IHC practice). |
Experiment evidence
IHC & IF images showing PDE4D staining
A01111-1 · IHCIHC analysis of PDE4D using anti-PDE4D antibody (A01111-1). PDE4D was detected in paraffin-embedded section of mouse lung tissue . Heat medi
A01111-1 · IHCIHC analysis of PDE4D using anti-PDE4D antibody (A01111-1). PDE4D was detected in paraffin-embedded section of human placenta tissue . Heat
HPA · Cerebral cortexHuman Protein Atlas IHC, Cerebral cortex. Source: https://www.proteinatlas.org/ENSG00000113448-PDE4D/tissue/cerebral+cortex#imid_12447105
HPA · ColonHuman Protein Atlas IHC, Colon. Source: https://www.proteinatlas.org/ENSG00000113448-PDE4D/tissue/colon#imid_12447015
HPA · LiverHuman Protein Atlas IHC, Liver. Source: https://www.proteinatlas.org/ENSG00000113448-PDE4D/tissue/liver#imid_12447024
HPA · KidneyHuman Protein Atlas IHC, Kidney. Source: https://www.proteinatlas.org/ENSG00000113448-PDE4D/tissue/kidney#imid_12447017
HPA · ICC-IF HeLaHuman Protein Atlas immunofluorescence, HeLa, antibody HPA045895; green = PDE4D, blue = nucleus, red = microtubules.
HPA · ICC-IF HeLaHuman Protein Atlas immunofluorescence, HeLa, antibody HPA045895; green = PDE4D, blue = nucleus, red = microtubules.
← swipe / scroll for more images →
Real IHC / IF data behind the staining-pattern expectations in this section.
Sample controls for PDE4D IHC & IF
🧪Start with colon; its glandular cells should stain (HPA: High in colon glandular cells). HPA detects PDE4D in all 45 scored tissues, so no negative tissue is available; use no-primary and isotype controls, and expect cells without discernible glandular-cell signal on the same slide to show only background rather than treating a named cell type as a validated negative (HPA: no negative rows; standard IHC practice).
Positive control tissue: Appendix (Glandular cells, HPA High)
Negative control tissue: None in HPA: PDE4D is detected in all 45 scored tissues. Use a no-primary (secondary-only) and an isotype control instead.
ICC-IF cell lines (HPA subcellular resource): HPA ICC-IF images show PDE4D in HeLa, ASC52telo, RPTEC/TERT1, hTERT-RPE1 (serum starved), KOLF2.1J, with annotated localisation: Plasma membrane (supported), Cytosol (uncertain) (HPA subcellular).
Technical controls: Run a no-primary, secondary-only control and a control IgG matched to the primary antibody’s host species, isotype and concentration; use PDE4D knockout material or immunizing-peptide competition, if available, as a biological specificity control (standard IHC practice). For the caption’s biotin/SABC–DAB detection, quench endogenous peroxidase and check for endogenous biotin background (selected tissue-IHC caption; standard IHC practice).
⚠️Feasibility: A target-specific fixation window or fixation effect is unreported, and the selected A01111-1 paraffin-section caption does not state the fixative (selected tissue-IHC caption). The caption uses citrate retrieval at pH 6 for 20 minutes on mouse lung; this is a starting condition to test in colon, not proof that colon staining depends on that retrieval condition (selected tissue-IHC caption). Available ICC-IF images do not establish that frozen sections or IF are easier for PDE4D; in colon IHC, inspect glandular lumina and mucus for nonspecific staining (HPA: subcellular ICC-IF images; standard IHC practice).
HPA tissue IHC evidence for PDE4D
Comprehensive Human Protein Atlas IHC scoring per tissue (reliability: Uncertain — Medium consistency between antibody staining and RNA expression data.). Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
Positive expression · recommended positive controls
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Appendix | Glandular cells | High | Protein (IHC) | HPA → |
| Cerebellum | Cells in granular layer | High | Protein (IHC) | HPA → |
| Colon | Glandular cells | High | Protein (IHC) | HPA → |
| Duodenum | Glandular cells | High | Protein (IHC) | HPA → |
| Endometrium | Cells in endometrial stroma | High | Protein (IHC) | HPA → |
Undetected expression · recommended negative controls
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| None in HPA: PDE4D is detected in all 45 scored tissues. Use a no-primary (secondary-only) and an isotype control instead. | ||||
Section 3
Advanced PDE4D IHC Tips
Troubleshoot PDE4D chromogenic IHC in paraffin sections by checking retrieval, staining distribution, and controls before interpreting signal intensity.
Which retrieval conditions should I use for weak PDE4D staining?
Use heat-mediated citrate retrieval at pH 6 for 20 minutes on paraffin sections (datasheet A01111-1). The documented mouse lung image used these conditions before incubation with 1 μg/mL catalog antibody overnight at 4°C (datasheet A01111-1). If staining is weak, check section adhesion, heating consistency, and antibody performance on a reference section before changing retrieval conditions (standard IHC practice). Compare any retrieval adjustment with the documented citrate condition on adjacent sections, because a stronger DAB signal can also reflect increased background or altered tissue morphology (standard IHC practice).
Could fixation explain weak or uneven PDE4D staining?
Target-specific PDE4D sensitivity to fixation is unknown from the supplied evidence; the catalog image identifies paraffin-embedded mouse lung but does not state its fixative (datasheet A01111-1). Record the actual fixative and processing history for each specimen, then compare sections processed alike when assessing staining differences (standard IHC practice). Examine morphology alongside DAB signal, since uneven processing or damaged sections can complicate comparisons across fields (standard IHC practice). Keep citrate pH 6 retrieval and the 1 μg/mL antibody condition consistent while investigating fixation, so a change in staining has fewer possible explanations (datasheet A01111-1; standard IHC practice).
Is cytoplasmic PDE4D staining credible when I expected membrane signal?
Yes: PDE4D has reported cytoplasmic, membrane-associated, cytoskeletal, and centrosomal localisation, without a transmembrane segment (UniProt Q08499 subcellular location and topology). HPA describes ubiquitous cytoplasmic tissue staining, while its cell imaging supports plasma membrane localisation and labels cytosolic localisation uncertain (HPA tissue IHC; HPA subcellular). In chromogenic sections, compare membrane-associated and cytoplasmic DAB patterns within morphologically intact cells and against a matched control section (standard IHC practice). A purely nuclear pattern needs additional validation before attribution to PDE4D, because HPA labels nucleoplasmic and nuclear-membrane locations uncertain (HPA subcellular).
Can this stain distinguish PDE4D isoforms or phosphorylation states?
Do not assign an isoform from DAB staining unless the catalog antibody's recognized epitope and its isoform coverage have been established (standard IHC interpretation). UniProt lists 12 PDE4D isoforms and a PDEase domain at residues 386–715, so epitope position matters when interpreting variants with different termini (UniProt Q08499 isoforms and domains). PDE4D also has reported phosphorylation sites, including serines 299 and 301, but ordinary PDE4D staining does not by itself identify a phosphorylation state (UniProt Q08499 modified residues; standard IHC interpretation). Use an independently validated isoform- or modification-specific reagent if that distinction is essential, and score its staining separately (standard IHC practice).
How should I investigate a PDE4D pattern with immunofluorescence?
Use IF as a follow-up localisation assay and multiplex PDE4D with a validated marker for the cell population being examined (standard IF practice). Choose fluorophores after inspecting unstained tissue autofluorescence, and reserve a spectrally distinct channel for the cell marker (standard IF practice). Because PDE4D lacks a transmembrane segment and can associate with the membrane from the cytoplasmic side, plan permeabilisation according to the antibody's known epitope accessibility rather than assuming an exposed surface epitope (UniProt Q08499 topology and subcellular location; standard IF practice). Compare the resulting pattern with IHC cautiously: HPA supports plasma membrane localisation in cell imaging, while its cytosolic assignment is uncertain (HPA subcellular).
What should I check when PDE4D DAB staining looks diffuse?
First compare stained sections with a primary-antibody omission control to locate signal arising from the detection system or endogenous tissue activity (standard IHC practice). The documented chromogenic workflow used 10% goat serum blocking, a biotinylated secondary antibody, a streptavidin–biotin complex, and DAB (datasheet A01111-1). Check peroxidase blocking and consider endogenous biotin as possible contributors when troubleshooting this detection chemistry, using appropriate control sections (standard IHC practice). Judge suspected background against intact-cell morphology and the reported cytoplasmic tissue profile; diffuse color over damaged areas or outside cells should not be scored as PDE4D expression (HPA tissue IHC; standard IHC practice).
How can I score PDE4D staining across paraffin sections? ⚠ ANSWER MARKED FOR VERIFICATION
Define the tissue compartment and cell type before scoring, then report the percentage of positive cells and staining intensity or a prespecified H-score (standard IHC practice). For an H-score, weight the proportions of cells at each intensity from 0 to 3, giving a range of 0–300 (standard IHC practice). Normalize counts to evaluable cells, or report positive-cell density per mm² of viable tissue when cell counts are impractical (standard IHC practice). Keep retrieval, DAB development, imaging, and positivity thresholds consistent, and compare matched cell populations because HPA reports high staining in several distinct tissue cell types (datasheet A01111-1; HPA tissue IHC; standard IHC practice).
When is a PDE4D-positive cell convincing rather than artefactual?
Prioritize staining in intact, identifiable cells with a plausible cytoplasmic or membrane-associated pattern, supported by a clean detection control (UniProt Q08499 subcellular location; HPA tissue IHC; standard IHC practice). HPA reports high staining in colon glandular cells and heart cardiomyocytes, but rates tissue IHC reliability uncertain because staining and RNA show only medium consistency (HPA tissue IHC). Treat isolated edge staining, necrotic regions, and color reproduced without primary antibody as possible artefacts; assess endogenous peroxidase when DAB signal persists in controls (standard IHC practice). Confirm any unexpected cell population or predominantly nuclear pattern with an independent reagent or assay before making a PDE4D-specific claim (HPA subcellular; standard IHC practice).
Boster reagents
Best PDE4D / 3',5'-cyclic-AMP phosphodiesterase 4D IHC Antibodies
A01111-1 has IHC images of paraffin sections from mouse lung, human placenta and rat lung (catalog IHC captions). ICC is listed, but no IF image is supplied (catalog applications; image inventory).
Real IHC data
Anti-PDE4D Antibody ®
Cat # A01111-1
A01111-1 will render with its mouse lung paraffin-section IHC figure (card caption). Its other IHC captions show human placenta and rat lung paraffin sections; Human, Mouse and Rat reactivity and ICC are listed (catalog IHC captions; catalog applications and reactivity).
Which to pick: Choose A01111-1 for tissue IHC: its image captions document paraffin sections stained at 1 μg/ml after citrate retrieval at pH 6 for 20 minutes (catalog IHC captions). For IF/ICC, A01111-1 lists ICC and 0.5–1 μg/ml, but supplies no IF image (catalog applications, IF dilution and image inventory). It is the listed cross-species choice for Human, Mouse and Rat; the host is Rabbit, the clone is unspecified, and the fixative is unreported (catalog reactivity, host and clone fields; IHC captions).
Each figure is that product's own IHC / IF validation image from its datasheet.
References
- UniProt Consortium. UniProt entry Q08499 (PDE4D_HUMAN, 3',5'-cyclic-AMP phosphodiesterase 4D).
- Human Protein Atlas. PDE4D tissue IHC expression (reliability: Uncertain).
- Human Protein Atlas. PDE4D subcellular location (ICC-IF): Mainly localized to the plasma membrane and cytosol. In addition localized to the nucleoplasm, nuclear membrane and primary cilium..
- Human Protein Atlas. PDE4D antibody validation summary (1 antibodies).
- ATP8B1 Deficiency Causes Phosphodiesterase 4-Mediated Glucagon Resistance and Impaired Gluconeogenesis in Mouse and Human Liver. Liver international : official journal of the International Association for the Study of the Liver 2025 — PMC12375944.
- Phosphodiesterase 4D promotes angiotensin II-induced hypertension in mice via smooth muscle cell contraction. Communications biology 2022 — PMC8776755.
- Phosphodiesterase PDE4D Is Decreased in Frontal Cortex of Aged Rats and Positively Correlated With Working Memory Performance and Inversely Correlated With PKA Phosphorylation of Tau. Frontiers in aging neuroscience 2020 — PMC7655962.
- High expression of PDE4D correlates with poor prognosis and clinical progression in pancreaticductal adenocarcinoma. Journal of Cancer 2019 — PMC6856734.
- PubMed PMID:8413254 — UniProt-cited evidence.
- PubMed PMID:8797812 — UniProt-cited evidence.
- PubMed PMID:8125310 — UniProt-cited evidence.
Immunohistochemistry protocol sheet for PDE4D (3',5'-cyclic-AMP phosphodiesterase 4D). Expected localisation Ubiquitous cytoplasmic tissue staining (HPA tissue IHC). Antigen retrieval: Citrate pH 6 HIER, heat-mediated (datasheet A01111-1). Validated IHC antibody: A01111-1 at 0.5-1μg/ml (the product's own IHC validation image is shown). Controls (HPA): positive Appendix (Glandular cells); negative None in HPA (detected in all 45 tissues); use no-primary + isotype controls. IHC-P workflow on paraffin sections; fixative unspecified. Protocol steps: 1. Sample: Paraffin-embedded mouse lung tissue; fixative not specified (datasheet A01111-1); 2. Fixation: Image fixative and duration unreported (datasheet A01111-1); verify before use.; 3. Sectioning: 4–5 µm sections on charged slides (standard); 4. Deparaffinisation: Xylene, graded ethanol series to water (standard); 5. Antigen retrieval: Heat retrieval: Citrate pH 6 , 20 min (datasheet A01111-1); 6. Peroxidase block: 3% H2O2, 10 min , room temperature (standard); 7. Blocking: 10% goat serum (datasheet A01111-1); 8. Primary antibody: Rabbit anti-PDE4D, 0.5-1μg/ml (datasheet A01111-1); 9. Primary incubation: Overnight at 4 °C (datasheet A01111-1). Watch for: Fixation: Keep fixation consistent across sections. (standard IHC practice; not target-specific); Caveat: Staining has uncertain concordance with RNA expression (HPA tissue IHC); Isoform / epitope: 12 isoforms vary at the N terminus; epitope coverage may differ (UniProt); Regulation: Specific expression regulators unreported (UniProt). Evidence: UniProt Q08499, HPA tissue IHC · Uncertain, HPA ICC-IF · Mainly localized to the plasma membrane and cytosol. In addition…, Datasheet A01111-1, PMC12375944, PMC7655962. QR code links to https://www.bosterbio.com/bosterbio-gene-info-cards/PDE4D/immunohistochemistry-ihc-guide.